Use of the NobleStitch™ EL for the treatment of patients with residual right-to-left shunt following device closure of PFO
- PMID: 33936617
- PMCID: PMC8077419
- DOI: 10.1002/ccr3.3906
Use of the NobleStitch™ EL for the treatment of patients with residual right-to-left shunt following device closure of PFO
Abstract
The unique design of the NobleStitch™ EL allows it to be used to close residual defects following failed device PFO closure without impacting the integrity of previously placed double-disk Gore occluders.
Keywords: Heartstitch; cryptogenic stroke; patent foramen ovale; platypnea‐orthodeoxia syndrome; residual shunt.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
None declared.
Figures



Similar articles
-
The effect of patent foramen ovale closure in patients with platypnea-orthodeoxia syndrome.Catheter Cardiovasc Interv. 2015 Oct;86(4):701-7. doi: 10.1002/ccd.25953. Epub 2015 Jun 9. Catheter Cardiovasc Interv. 2015. PMID: 26063336
-
Comparison of residual shunt rates in five devices used to treat patent foramen ovale.Catheter Cardiovasc Interv. 2014 Sep 1;84(3):455-63. doi: 10.1002/ccd.25453. Epub 2014 Mar 4. Catheter Cardiovasc Interv. 2014. PMID: 24550064
-
Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale.Catheter Cardiovasc Interv. 2020 Feb 15;95(3):365-372. doi: 10.1002/ccd.28527. Epub 2019 Oct 26. Catheter Cardiovasc Interv. 2020. PMID: 31654558
-
To close or not to close: contemporary indications for patent foramen ovale closure.Expert Rev Cardiovasc Ther. 2016 Nov;14(11):1235-1244. doi: 10.1080/14779072.2016.1224178. Epub 2016 Sep 10. Expert Rev Cardiovasc Ther. 2016. PMID: 27616622 Review.
-
Platypnea-orthodeoxia syndrome in the elderly treated by percutaneous patent foramen ovale closure: a case series and literature review.Eur J Intern Med. 2013 Dec;24(8):813-7. doi: 10.1016/j.ejim.2013.08.698. Epub 2013 Sep 3. Eur J Intern Med. 2013. PMID: 24007641 Review.
Cited by
-
Updates on Patent Foramen Ovale (PFO) Closure.Curr Cardiol Rep. 2024 Jul;26(7):735-746. doi: 10.1007/s11886-024-02073-y. Epub 2024 Jun 24. Curr Cardiol Rep. 2024. PMID: 38913234 Review.
-
Traumatic Atrial Septal Defect Repair via Primary Endovascular Suture Method: Case Report and Operative Technique.Cureus. 2023 Jan 12;15(1):e33679. doi: 10.7759/cureus.33679. eCollection 2023 Jan. Cureus. 2023. PMID: 36788870 Free PMC article.
-
Persistence of residual shunt at 6 and 12 months after transoesophageal echocardiography-guided percutaneous closure of a patent foramen ovale for cryptogenic stroke.Heart. 2024 Sep 16;110(19):1172-1179. doi: 10.1136/heartjnl-2024-323905. Heart. 2024. PMID: 39122559 Free PMC article.
-
Transcatheter Interventions in Patients With Adult Congenital Heart Disease.J Soc Cardiovasc Angiogr Interv. 2022 Aug 24;1(6):100438. doi: 10.1016/j.jscai.2022.100438. eCollection 2022 Nov-Dec. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39132367 Free PMC article. Review.
References
-
- Abdelghani M, El‐Shedoudy SAO, Nassif M, Bouma BJ, de Winter RJ. Management of patients with patent foramen ovale and cryptogenic stroke: An update. Cardiology. 2019;143(1):62‐72. - PubMed
-
- Matsumura K, Gevorgyan R, Mangels D, Masoomi R, Mojadidi MK, Tobis J. Comparison of residual shunt rates in five devices used to treat patent foramen ovale. Catheter Cardiovasc Interv. 2014;84(3):455‐463. - PubMed
-
- Rana BS, Shapiro LM, McCarthy KP, Ho SY. Three‐dimensional imaging of the atrial septum and patent foramen ovale anatomy: defining the morphological phenotypes of patent foramen ovale. Eur J Echocardiogr. 2010;11(10):i19‐25. - PubMed
-
- Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59(1):17‐20. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources